|
|
Volumn 9, Issue 14, 2002, Pages 1359-1366
|
|
The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson's disease: A review of the literature
|
|
Author keywords
Parkinson's disease; Pharmacological treatment; Speech therapy
|
|
Indexed keywords
APOMORPHINE;
BENZATROPINE MESILATE;
BROMOCRIPTINE MESILATE;
CABERGOLINE;
CARBIDOPA PLUS LEVODOPA;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOPAMINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
MONOAMINE OXIDASE B INHIBITOR;
PERGOLIDE MESILATE;
PLACEBO;
PRAMIPEXOLE;
ROPINIROLE;
SELEGILINE;
TOLCAPONE;
TRIHEXYPHENIDYL;
ANTIPARKINSON AGENT;
BENZOTHIAZOLE DERIVATIVE;
MONOAMINE OXIDASE INHIBITOR;
PRAMIPEXOL;
THIAZOLE DERIVATIVE;
CONTROLLED STUDY;
DOPAMINE BRAIN LEVEL;
DRUG EFFECT;
DYSARTHRIA;
HUMAN;
LOUDNESS;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
PARKINSON DISEASE;
PATIENT CARE;
PHONATION;
PITCH;
REVIEW;
SPEECH ARTICULATION;
SPEECH DISORDER;
SPEECH THERAPY;
VOCALIZATION;
VOICE;
PHYSIOLOGY;
SPEECH;
ANTIPARKINSON AGENTS;
BENZOTHIAZOLES;
CHOLINERGIC ANTAGONISTS;
DYSARTHRIA;
HUMANS;
MONOAMINE OXIDASE INHIBITORS;
PARKINSON DISEASE;
SPEECH;
SPEECH THERAPY;
THIAZOLES;
VOICE;
|
|
EID: 0035986462
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867023369808 Document Type: Review |
|
Times cited : (27)
|
|
References (96)
|
